Late thrombotic occlusion of paclitaxel eluting stent more than one year after stent implantation

Use of drug eluting stents has become the state-of-the-art therapy for percutaneous treatment of obstructive coronary artery disease. However, concern has been expressed on the delayed healing after implantation of a drug eluting stent. We present the first report of late thrombotic occlusion of a paclitaxel eluting stent (Taxus, Boston Scientific Corp) at just more than one year after implantation. A 44 year old Indian man underwent implantation of a 3.0/24 mm paclitaxel eluting …